Limpong, Baby Girl .

HRN: 25-45-97  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/10/2024
AMPICILLIN 250MG (VIAL)
07/10/2024
07/17/2024
IVTT
70
Q12H
PSNB
Waiting Final Action 
07/10/2024
GENTAMICIN 40MG/ML, 2ML (AMP)
07/10/2024
07/17/2024
IVTT
7
Q24H
PSNB
Waiting Final Action 
07/20/2024
CEFOTAXIME 500MG (VIAL)
07/20/2024
07/26/2024
IV
70mg
Q6
Neonatal Sepsis
Waiting Final Action 
07/20/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/20/2024
07/26/2024
IV
17
Q24
Neonatal Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: